|
- Login | Bausch + Lomb US
Note to consumers: Bausch + Lomb Direct Ordering is intended for use by Eye Care Professionals and Retailers Please contact your Eye Care Professional to order Bausch + Lomb products
- Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife . . .
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens May 07 2025 VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for the LuxLife full range of vision intraocular lens (IOL)
- MEDIA ASSET LIBRARY - bausch. com
©2025 Bausch + Lomb MTB 0115 USA 21 All Information and m aterials on this site pertain to the U S only, unless otherwise indicated
- Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista . . .
Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses Mar 27 2025 VAUGHAN, Ontario, UPDATED April 3, 2025 – Bausch + Lomb Corporation (NYSE TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) on its
- Guia para Adaptação de Lentes Esclerais - bausch. com
iii equipe editorial Lynette Johns tem sido optometrista principal na fundação Boston Foundation for Sight desde 2005 Formou-se no New England College of Optometry, onde completou a residência em córnea e lentes de contato É membro clínico adjunto no New England College of
- ir. bausch. com
ir bausch com
- Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results . . .
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance Feb 19 2025 Fourth-Quarter 2024 Financial Results Revenue of $1 280 Billion; GAAP Net Loss Attributable to Bausch + Lomb Corporation of $3 Million; Adjusted EBITDA excluding Acquired IPR D (non-GAAP) 1 of $259 Million Revenue Grew 9% as Reported and 11% on a Constant Currency 1 Basis Compared to the
- Bausch + Lomb Official Home Page
Bausch + Lomb is one of the world's largest suppliers of contact lenses, lens care products, prescription pharmaceuticals, intraocular lenses and other eye surgery products
|
|
|